Registry of Lobbyists
| Subject matters | Details | Categories |
|---|---|---|
|
Government Procurement, Health, Intellectual Property, Science and Technology, Taxation and Finance
|
Communications regarding funding from various Government funding programs, opportunities to improve government activity (funding, tax incentives, clinical trials infrastructure, etc) to encourage the innovation economy in Canada with a specific focus on biotech, and programs around procurement opportunities for the Government of Canada relating to biotechnology products.
|
Policies or Program, Grant, Contribution or Other Financial Benefit
|
Small technology company focused on discovering antibodies from natural sources for development into therapeutic products.
Carl Hansen, President
End date of the last completed financial year: 2023-12-31
| Government Institution | Funding Received in Last Financial Year | Funding Expected in Current Financial Year |
|---|---|---|
| Strategic Innovation Fund (SIF) | $49,300,382.74 | Yes |
Address:
2215 Yukon Street
Vancouver, BC V5Y 0A1
Canada
Telephone number:
604-559-9005
AbCellera Biologics Inc. is not a subsidiary of any other parent companies.
AbCellera Biologics Inc. does not have any subsidiaries that could have a direct interest in the outcome of the undertaking